| Mrs Amy Doornbos, PA | |
|
5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 | |
| (989) 791-2330 | |
| (989) 791-2329 |
| Full Name | Mrs Amy Doornbos |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 18 Years |
| Location | 5400 Mackinaw Rd, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275710386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 5601004865 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-west Branch | West branch, MI | Hospital |
| Covenant Medical Center | Saginaw, MI | Hospital |
| Tawas St Joseph Hospital | Tawas city, MI | Hospital |
| Midmichigan Medical Center-gladwin | Gladwin, MI | Hospital |
| Ascension St Mary's Hospital | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology Hematology Associates Of Saginaw Valley, P.c. | 1355328550 | 5 |
News Archive
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure® procedure will be highlighted at the 18th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE) in Florence, Italy from October 28-31, 2009.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients.
A new study finds that not only low but also high maternal thyroid hormone levels during early pregnancy may significantly lower the infant's IQ later in childhood. The study results, which will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego, suggest that the common practice of treating pregnant women who have mild thyroid hormone deficiency may pose unexpected risks to the developing baby's brain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Doornbos, PA 5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 Ph: (989) 791-2330 | Mrs Amy Doornbos, PA 5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 Ph: (989) 791-2330 |
News Archive
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure® procedure will be highlighted at the 18th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE) in Florence, Italy from October 28-31, 2009.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.
ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients.
A new study finds that not only low but also high maternal thyroid hormone levels during early pregnancy may significantly lower the infant's IQ later in childhood. The study results, which will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego, suggest that the common practice of treating pregnant women who have mild thyroid hormone deficiency may pose unexpected risks to the developing baby's brain.
› Verified 7 days ago
Mrs. Lindsey Pilling, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave Ste 3100, Saginaw, MI 48602 Phone: 989-583-7450 Fax: 989-583-7452 | |
Marcus S Breidinger, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 912 S Washington Ave, Suite 1, Saginaw, MI 48601 Phone: 989-790-1001 Fax: 989-790-1002 | |
Jean Noel Barker, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-0000 | |
Mr. Michael Vincent Michalak, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1015 S Washington Ave, Saginaw, MI 48601 Phone: 989-754-3000 Fax: 989-755-1365 | |
Jason Maxa, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Suite 3100, Saginaw, MI 48602 Phone: 989-583-7450 Fax: 989-583-7452 | |
Paul Edward Mckellip, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 S Washington Ave, Saginaw, MI 48601 Phone: 989-987-8000 | |
Jennifer Radewahn, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 4705 Towne Ctr, Ste 102, Saginaw, MI 48604 Phone: 989-790-2941 Fax: 989-790-2983 |